Professor Dan Chambers
Professor Dan Chambers is a Thoracic and Transplant Physician with long-standing clinical and research interests in lung fibrosis. Dan is Associate Director of the International Lung and Heart-lung Transplant Registry and runs one of the largest pulmonary fibrosis clinical trials centres in Australia. His research has been supported by over $13 million in competitive grant funding. He has been principal investigator for multiple trials from phases 1 to 3 in lung fibrosis, cellular therapy and lung transplantation.
Dan graduated from the University of Queensland, before undertaking much of his specialist and transplant training in the UK. He co-founded the Western Australian lung transplant program before returning to Brisbane in 2008. Dan is Chair of Pulmonary Fibrosis Australasian Clinical Trials Network (PACT).
Associate Professor Tamera Corte
A/Prof. Tamera Corte is a Consultant Respiratory Physician and Director of Interstitial Lung Disease at Royal Prince Alfred Hospital, an Associate Professor at the University of Sydney and is the Chair of the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry, and a member of multiple international task forces.
A/Prof. Corte served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London and has a PhD in the identification of pulmonary vascular dysfunction in interstitial lung disease. She continues her research at Sydney University, where she is Chief Investigator on a Centre of Excellence NHMRC grant for Pulmonary Fibrosis.
Dr Ian Glaspole
Dr Ian Glaspole is the head of the Alfred Hospital interstitial lung disease clinic and an adjunct clinical associate professor within the Monash University Faculty of Medicine. His research is principally to do with clinical aspects of interstitial lung disease. He is the co-Chair of the Australian Idiopathic Pulmonary Fibrosis Registry, which has formed an important part of a number of NHMRC funded projects, including the Centre for Research Excellence in Pulmonary Fibrosis.
Dr Nicole Goh
Dr Nicole Goh is a Consultant Respiratory Physician and Director of the Interstitial Lung Disease Unit at Austin Health, Chair of the Medical and Scientific Research Committee at the Institute of Breathing and Sleep, and is on the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry.
Dr Goh served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London and has a PhD in the identification of prognostic markers in scleroderma associated interstitial lung disease. She continues her research at Austin Health and has a particular interest in pulmonary rehabilitation and oxygen therapy in interstitial lung disease.
A/Prof Chris Grainge
A/Prof Chris Grainge is the Director of the Interstitial Lung Disease service at the John Hunter Hospital in Newcastle, the largest Australian clinic outside an capital city and one of the largest in the country. As well as the clinical service, he and a large group of dedicated lung scientists based at the Hunter Medical Research Centre are researching the causes of interstitial lung disease, how these diseases affect different cell types in the lungs and how their progression can be halted and the disease improved. The combination of a busy clinical service and a dedicated research team allow the group to approach interstitial lung disease at every level, from fundamental science aiming to understanding the disease, to involvement in clinical trials.
Professor Anne Holland
Professor Anne Holland is Clinical Chair in Physiotherapy at Alfred Health in Melbourne, a joint appointment with La Trobe University. Her research program aims to optimise non-pharmacological management for people with chronic respiratory disease.
Anne led the first randomized controlled trial of pulmonary rehabilitation for people with pulmonary fibrosis, a treatment that is now recommended in clinical guidelines across the world. Her current clinical trials investigate new models of pulmonary rehabilitation to improve access and uptake, and ambulatory oxygen therapy for pulmonary fibrosis. In the CRE for Pulmonary Fibrosis she leads programs to optimize patient education and support, and improve translation of research into best clinical practice.
Associate Professor Peter Hopkins
Associate Professor Peter Hopkins is the Director of The Queensland Lung Transplant Service and on the Board of Directors, International Society of Heart and Lung transplantation. He is the Chairman elect of the Standards and Guidelines Committee of ISHLT and previously chaired the Lung Advisory Committee of the Transplant Society of ANZ. He holds multiple executive positions on national and international bodies including the Australian IPF Registry, Rare Lung Diseases Committee and has been chair of the Interventional Pulmonology and OLIV SIG for TSANZ.
Professor Andrew Palmer
Professor Andrew Palmer has over 24 years’ experience in the area of health economics research, and is widely published and internationally respected. He studied medicine at the University of Tasmania, worked at the Launceston General Hospital, then as a general practitioner in Sydney. In 1994 he moved to Switzerland, where he was Medical Director of the Institute for Medical Informatics and Biostatistics and co-founded CORE, Center for Outcomes Research in Basel, Switzerland.
Andrew is the Founding Chair of Health Economics at the Menzies Institute for Medical Research, University of Tasmania, and is the Public Health and Primary Care theme leader. He leads the health economics studies of the Centre of Excellence NHMRC grant for Pulmonary Fibrosis.
Professor Margaret Wilsher
Professor Margaret Wilsher is respiratory physician and Chief Medical Officer, Auckland District Health Board and Honorary Professor, University of Auckland. She trained at Otago University, Green Lane Hospital and the Royal Brompton Hospital/National Heart and Lung Institute developing a career long interest in interstitial lung diseases with current research interests in sarcoidosis and the ageing lung. Professor Wilsher also sits on a number of national and Ministerial boards and committees in New Zealand including the advisory board for the NZ Health Research Strategy.
Ms Jennifer Walsh
Ms Jennifer Walsh is a Project Manager for the Centre of Research Excellence in Pulmonary Fibrosis at the University of Sydney. She is also the Project Manager for the Australian Genomics and Clinical Outcomes of Glioma (AGOG) research study at the University of New South Wales.
Jennifer holds a Bachelor of Science and Master of Public Health qualifications and extensive experience as a Project Manager involved in several research projects in public health and cancer research settings. Jennifer is especially interested in cancer epidemiology.